Anheuser-Busch InBev NV faces a European Union antitrust investigation into practices that may prevent cheaper Dutch and French beer being sold in its home market of Belgium.
The European Commission will probe whether changing beer packaging or limiting rebates for non-Belgian retailers hinders imports to Belgium, according to an e-mailed statement. The EU regulator’s “preliminary view is that AB InBev may be pursuing a deliberate strategy to restrict so-called parallel trade of its beer.”
The commission last month approved AB InBev’s $104 billion bid to buy beer rival SABMiller Plc after the companies agreed to sell almost all of SABMiller’s business in Europe to allay concerns it could control the region’s beer market. Today’s antitrust probe could pave the way to fines or an order to change business practices.
AB InBev is “fully cooperating with the European Commission,” said spokesman Korneel Warlop. He refused to comment on the substance of potential consequences of the probe.
The brewer of Budweiser, which has a 53 percent share of Belgium’s beer market, was previously probed by the EU for colluding to fix prices in the Netherlands. It escaped fines in 2007 because it was the first to tell the commission about the cartel.
AB InBev is still seeking approval from global regulators for the SABMiller deal. In the US, which is yet to approve the transaction, AB InBev has come under fire from state representatives and smaller craft brewers for alleged attempts at curbing competition by incentivizing or acquiring distributors.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Fires Head of Copyright Office, Throwing U.S. AI Policy Into Disarray
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
H-E-B Joins Antitrust Battle Against Teva Over MS Drug Monopoly
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece